Our history

2016

Nov 2016 AIFA grants authorization for the new production building
READ

2014

New production building starts

2010

EDQM first edition, updated Jul 2015 CEP for Heparin Calcium

2009

Japanese MoH PMDA approves manufacturing site for Heparinoid JP and Heparin Sodium production

2008

Senté Inc. – USA. License agreement to supply Heparan Sulfate for cosmetic application. Sentè is a leading aesthetic company pioneering glycosaminoglycans (GAGs) science in skincare. SENTÉ combines grassroots in biotechnology with pharmaceutical rigor in the development of skincare formulations.

2006

LDO Plant was accredited by Japan MHLW (AG22000008)

2006

EDQM first edition, updated Jan 2011 CEP for Heparin Calcium

2005

Contract signing with Hunter-Fleming (now NEWRON) on LMWHep (HF0420)

2004

Iranian MoH grants its approval for Heparin Sodium

1986

First γ -irradiation test to obtain LMW Hep

1974

First Heparin Sodium production from Italian pig Mucosa

1964

MoH grants Authorization to produce APIs. LDO is now one of the leading companies in the field of Biological APIs manufacturing

1960

Foundation of LDO as manufacturer of organotherapeutic products, specializing in the extraction of active ingredients of biological origin from animal organs.